Skip to main content
. 2015 Mar 12;6(3):e1687. doi: 10.1038/cddis.2015.47

Figure 6.

Figure 6

Models depicting SPOP-mediated ERα degradation in physiological and pathological conditions in endometrial cancer. (a) Unmutated SPOP promotes degradation of wild-type ERα. (b) Endometrial cancer-associated mutants of SPOP are defective in promoting ERα ubiquitination and degradation. (c) Estrogen potentiates SPOP-mediated ERα degradation